Mathias Schmidt

Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial

Roberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar et al. · Orphanet Journal of Rare Diseases · 2018 · 137 citations · Full text

EGF receptor and p185^erbB‐2‐specific single‐chain antibody toxins differ in their cell‐killing activity on tumor cells expressing both receptor proteins

Winfried S. Wels, Roger R. Beerli, P. Hellmann et al. · International Journal of Cancer · 1995 · 97 citations

Immunology, Cell Death, Tumor Cells +17

Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2

Marc Azémar, S. Djahansouzi, Elke Jäger et al. · Breast Cancer Research and Treatment · 2003 · 95 citations

Medicine, Immunoediting, Pathology +7

The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy

Marcel Leist, Susanne Bremer, Patrik Brundin et al. · ALTEX · 2008 · 73 citations · Full text

Overexpression of polo-like kinase 1 is a common and early event in pancreatic cancer

Wilko Weichert, Mathias Schmidt, Juliane Jacob et al. · Pancreatology · 2005 · 63 citations

Pancreatic Cancer, Medicine, Pathology +7